BioSpace News Archive

Human hands holding colorful puzzle pieces in 80s retro collage vector illustration. Mixed media artwork for concept of cooperation, teamwork, partnership and successful solutions.

Editorial

The People Behind Biopharma’s Big Wins: Personal Stories From JPM25

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and pharma executives—and the general comradery in the air throughout the chaotic event.

January 17, 2025

·

4 min read

·

Annalee Armstrong

Novartis' office building in Marburg, Germany

Patents

Novartis Scrambles to Squelch Copycats as Generics Gain Ground

Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug Entresto.

January 17, 2025

·

2 min read

·

Tristan Manalac

A piggy bank crammed with $100 bills on a background of American cash

Drug pricing

Novo’s Ozempic, Wegovy Targeted in Second Round of IRA Drug Price Negotiations

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare negotiations or not. CMS has until June 1 to send an initial offer for the adjusted prices.

January 17, 2025

·

3 min read

·

Tristan Manalac

Facade of AstraZeneca's office in Shanghai, China

FDA

AstraZeneca Gets Full FDA Approval for CMS-Selected Lymphoma Treatment

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the 15 products to be subject to IRA-prescripted price negotiations for Medicare this year.

January 17, 2025

·

1 min read

·

Dan Samorodnitsky

glp-1

Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial

The data suggest the high dose nearly closes the efficacy gap with Zepbound.

January 17, 2025

·

3 min read

·

Nick Paul Taylor

Pictured: Boehringer Ingelheim sign on a building/

Schizophrenia

Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS

Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug price negotiation program.

January 17, 2025

·

2 min read

·

Tristan Manalac

Halftone collage banner, palm and magic glass ball floating in the air on a dark background. Magic clouds, stars, pop art poster.

Deals

The Biopharma Crystal Ball Comes Out at JPM25

Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea for the slow, healthy recovery of the industry at large.

January 17, 2025

·

3 min read

·

Annalee Armstrong

Amgen sign at its headquarters in Thousand Oaks, California, USA.

Approvals

Looking Beyond Obesity, Amgen Wins Colorectal Cancer Expansion for Lumakras

The Phase III CodeBreaK 300 study returned disappointing overall survival data for Lumakras plus Vectibix in metastatic colorectal cancer, but in its approval announcement, the FDA pointed to significant improvements in progression-free survival, calling it the “major efficacy outcome” of the trial.

January 17, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 17, 2025

·

2 min read

Press Releases

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 17, 2025

·

2 min read